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Fig. S1. Solvent-dependent stability of RSV. (a) Concentration-dependent colour change in diverse solvents mimicking 
physiological conditions after ~16 hours incubation with RSV. (b) Concentration-dependent colour change of cell culture 
medium (KGM, keratinocyte growth medium) due to 16 hours of incubation with RSV. (c) Kinetic measurement of light 
absorbance at maximum of RSV (308 nm) at 37°C in various solvents. Dotted line indicates putative beginning of evaporation. 
Detailed view on kinetic absorbance measurement from Fig. S1c (d). RSV reacts efficiently indicated by the linear and time-
dependent decrease of absorbance. Values are mean (n = 3). See also Table S1. & 50 µM RSV, § 100 µM RSV. KGM, 
keratinocyte growth medium (e) Fluor-de-Lys assay to determine intact RSV after ~16 hours incubation. Values are mean ± 
s.e.m. (n = 4).
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Fig. S2. RSV produces ROS, which can be diminished by NaHCO3 and quenched by potent antioxidant GSH. (a) Intracellular 
ROS generation after 16 hours of RSV treatment of NHEK cells. Values are mean ± s.e.m. (n = 6), ** P < 0.01 one-way ANOVA 
versus vehicle. AUC, area under the curve. (b) Summed ROS generation in after incubation of vehicle (V) or RSV (R) in H2O 
with or without 44 mM NaHCO3 at 37°C (cell-free). Values are mean ± s.e.m. (n = 3). Bi, 44 mM NaHCO3. (c and d) Kinetic (c) 
and summed (d) ROS generation derived from 50 µM RSV incubated in KGM (cell-free). Values are mean ± s.e.m. (n = 2-4). 
AUC, area under the curve. (e) H2O2 generation after 16.5 hours. Values are mean ± s.e.m. (n = 4). (f) Inhibition of ABTS 
oxidation by Trolox and RSV (left). 44 mM NaHCO3 diminished antioxidant features of RSV roughly 2-fold (see dash-dot-dot 
line) (right). Values are mean ± s.e.m. (n = 3). (g) Macroscopical appearance of NHEKs treated with 50 µM RSV for 16 hours. 
Scale bar indicating 100 µm. (h and i) GSH considerably quenched RSV-driven ROS generation in KGM (cell free) (h) and in 



























































































































































































































































































































Fig. S3. RSV-driven expression of Nrf2 target genes observed in diverse cellular models and rarely concentration-dependent. 
(a, b, c and d) RSV effects are in principle similar for most cellular models tested. Values are ± s.e.m. (n = 4); # P <0.05 One-
way ANOVA with subsequent Dunnett’s post-test versus RSV-treated NHEKs. (e, f, g and h) The highest impact on gene 
expression without adverse effects is observed after 16 hours of treatment with 50 µM or 100 µM RSV. Values are mean ± 
s.e.m. (n = 4); # P < 0.05 versus vehicle. See also Figure 3a-d.
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Fig. S4. The transcription factor Nrf2 mediates RSV effects. (a) Scheme of canonical Nrf2 signaling. Under physiological 
conditions Nrf2 resides in the cytoplasm as it is bound to its inhibitor Keap1, which facilitates ubiquitination via Cul3. Oxidative 
stress enables formation of bisulfide bonds in Keap1. Resulting conformational change of Keap1 triggers release of Nrf2, and 
its subsequent phosphorylation and translocation into the nucleus to enhance expression of anti-oxidative and other target 
genes. (b) Fluorescence staining marking DAPI (blue), Nrf2 (green) and Keap1 (magenta) in treated NHEKs. Scale bar equals 
25 µm.  
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Protein content after Nrf2 knockdown

























Fig. S5. Cellular effects of RSV are mediated by transcription factor Nrf2 and result in G1 phase cell cycle arrest. (a) 
Quantification of protein content upon Nrf2 knockdown in treated (50 µM RSV) NHEKs. Densitometric analysis was done 
relative to negative siRNA vehicle. All gels were run under the same experimental conditions and cropped blots depicted 
(copping: dashed line). Values are mean ± s.e.m. (n = 3); * P < 0.05, ** P < 0.01, *** P ≤ 0.001 one-way ANOVA versus 
negative siRNA vehicle. V, vehicle; R, RSV. (b) RSV substantially induced expression of autophagy marker genes in treated 
NHEKs. Values are mean ± s.e.m. (n = 4); ** P < 0.01, *** P ≤ 0.001 versus vehicle. (c) 50 µM RSV induced G1 phase arrest in 
treated NHEK cells. Densitometric analysis of immunoblots was done relative to vehicle. All gels were run under the same 
experimental conditions and cropped blots depicted (copping: dashed line). Values are mean ± s.e.m. (n = 4); * P < 0.05; ** P < 
0.01, *** P ≤ 0.001 versus vehicle. (d) Senescence marker genes are diversely regulated in NHEKs by RSV treatment. Values 
are mean ± s.e.m. (n = 4); * P < 0.05, ** P < 0.01, *** P ≤ 0.001 versus vehicle. (e) RSV increased expression of pro-apoptotic 
genes while decreasing expression of anti-apoptotic BIRC5 in treated NHEKs. Values are mean ± s.e.m. (n = 4); * P < 0.05, ** 
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Fig. S6. Cellular effects of RSV are in part modulated by sirtuins. (a) Translocation of SIRT1 and increased amount of nuclear 
phosphorylated SIRT1 as well as SIRT1 protein. Densitometric analysis was done relative to vehicle. All gels were run under 
the same experimental conditions and cropped blots depicted (copping: by dashed line). Values are mean ± s.e.m. (n = 4); * P 
< 0.05, ** P < 0.01 versus vehicle. (b) Knockdown efficiency in RSV treated NHEKs. Knockdown of SIRT1 resulted in 20 % 
lower expression of Nrf2. are mean ± s.e.m. (n = 4); * P < 0.05 one-way ANOVA versus negative siRNA. (c) Quantification of 
gene expression upon knockdown of SIRT1 in RSV treated NHEKs. Values are mean ± s.e.m. (n = 4); * P < 0.05 one-way 
ANOVA versus negative siRNA vehicle. (d) Protein content upon knockdown of SIRT1 in RSV treated NHEKs.  Densitometric 
analysis was done relative to negative siRNA vehicle. All gels were run under the same experimental conditions and cropped 
blots depicted (copping: dashed line). Values are mean ± s.e.m. (n = 3); * P < 0.05, ** P < 0.01, *** P ≤ 0.001 one-way ANOVA 
versus negative siRNA vehicle. V, vehicle; R, RSV.  
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Fig. S7. RSV influences metabolite ratios, subsequently shifting the cellular redox environment to a reduced state. (a) RSV 
increased phosphorylation of pyruvate dehydrogenase subunit E1 α (PDE1α) at serine 293. Densitometric analysis was 
performed relative to vehicle. All gels were run under the same experimental conditions and cropped blots depicted (copping: 
dashed line). Values are mean ± s.e.m. (n = 4); ** P < 0.01 versus vehicle. (b) 50 µM RSV failed to induce mitochondrial 
biogenesis in RSV treated NHEKs. Values are mean ± s.e.m. (n = 4); n.s., not significant (c) RSV decreased mitochondrial 
oxygen consumption in RSV treated NHEKs. Values are mean ± s.e.m. (n = 8); *** P ≤ 0.001 versus vehicle. (d) Calculated 
metabolite ratios (see Figure 5a); * P < 0.05, ** P < 0.01. (e) Fluorescence staining marking DAPI (blue), Glutamate-cysteine 
ligase catalytic subunit (GCLC, green) and glutathione-disulfide reductase (GSR, magenta) in RSV treated NHEKs. (f) 




Supplementary Material and Methods 
 
Parameter KGM# DMEM$ 
Slope -0.031 ± 0.0004 -0.059 ± 0.0007 
Y-intercept (X=0.0) 0.467 ± 0.0027 0.836 ± 0.0043 
X-intercept (Y=0.0) 15.04 14.15 
R square 0.9844 0.9887 
P value < 0.0001 < 0.0001 
Table S1. Linear regression of RSV degeneration in cell culture media. Results of 
the linear regression analyses of data presented in Fig. S1d. & 50 µM RSV, § 100 µM 
RSV. KGM, keratinocyte growth medium. 
 
 
Name NES FDR q-val 
SPLICEOSOME -2.581 0.000 
RNA DEGRADATION -2.340 0.000 
DNA REPLICATION -2.239 0.000 
CELL CYCLE -2.143 0.000 
LYSOSOME 2.160 0.000 
SYSTEMIC LUPUS ERYTHEMATOSUS 2.110 0.001 
METABOLISM OF XENOBIOTICS BY CYTOCHROME P450 1.882 0.015 
STEROID HORMONE BIOSYNTHESIS 1.898 0.015 
OTHER GLYCAN DEGRADATION 1.907 0.017 
ADIPOCYTOKINE SIGNALING PATHWAY 1.847 0.021 
PENTOSE AND GLUCURONATE INTERCONVERSIONS 1.821 0.025 
PYRUVATE METABOLISM 1.777 0.029 
PPAR SIGNALING PATHWAY 1.779 0.031 
PEROXISOME 1.784 0.034 
EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI 
INFECTION 
1.745 0.034 
NATURAL KILLER CELL MEDIATED CYTOTOXICITY 1.732 0.035 
GLUTATHIONE METABOLISM 1.750 0.036 
NITROGEN METABOLISM 1.719 0.038 
CYTOKINE CYTOKINE RECEPTOR INTERACTION 1.732 0.038 
DRUG METABOLISM CYTOCHROME P450 1.691 0.043 
RETINOL METABOLISM 1.699 0.044 
PROXIMAL TUBULE BICARBONATE RECLAMATION 1.691 0.045 
FATTY ACID METABOLISM 1.680 0.045 
PURINE METABOLISM -1.747 0.055 
ARACHIDONIC ACID METABOLISM 1.647 0.060 
PYRIMIDINE METABOLISM -1.721 0.061 
SPHINGOLIPID METABOLISM 1.637 0.062 
 
 
TOLL LIKE RECEPTOR SIGNALING PATHWAY 1.626 0.066 
PROPANOATE METABOLISM 1.620 0.067 
GLYCINE SERINE AND THREONINE METABOLISM 1.587 0.087 
VALINE LEUCINE AND ISOLEUCINE DEGRADATION 1.564 0.094 
LIMONENE AND PINENE DEGRADATION 1.568 0.095 
GLYCEROLIPID METABOLISM 1.572 0.095 
BUTANOATE METABOLISM 1.552 0.097 
FC EPSILON RI SIGNALING PATHWAY 1.557 0.097 
STEROID BIOSYNTHESIS 1.530 0.102 
TASTE TRANSDUCTION 1.526 0.103 
B CELL RECEPTOR SIGNALING PATHWAY 1.533 0.103 
CELL ADHESION MOLECULES CAMS 1.538 0.103 
RNA POLYMERASE -1.633 0.126 
NOD LIKE RECEPTOR SIGNALING PATHWAY 1.467 0.152 
ONE CARBON POOL BY FOLATE -1.595 0.153 
CHEMOKINE SIGNALING PATHWAY 1.459 0.157 
GLYCOSAMINOGLYCAN BIOSYNTHESIS KERATAN 
SULFATE 
1.445 0.167 
PROTEASOME -1.557 0.168 
OOCYTE MEIOSIS -1.568 0.170 
AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM 1.431 0.174 
TRYPTOPHAN METABOLISM 1.426 0.175 
ARGININE AND PROLINE METABOLISM 1.432 0.177 
FC GAMMA R MEDIATED PHAGOCYTOSIS 1.420 0.178 
INOSITOL PHOSPHATE METABOLISM 1.400 0.193 
GLYCOSAMINOGLYCAN BIOSYNTHESIS CHONDROITIN 
SULFATE 
1.401 0.197 
PROGESTERONE MEDIATED OOCYTE MATURATION -1.522 0.199 
CITRATE CYCLE TCA CYCLE 1.382 0.212 
BASE EXCISION REPAIR -1.475 0.218 
NUCLEOTIDE EXCISION REPAIR -1.460 0.224 
ECM RECEPTOR INTERACTION -1.480 0.227 
AMINOACYL TRNA BIOSYNTHESIS -1.482 0.243 
Table S2. Enriched KEGG pathways using (GSEA). Gene expression data were 
submitted to Gene Expression Omnibus database (GSE72119). GSEA was performed 
using parameters described in experimental procedures. Microarray data were 
analysed using the curated C2 KEGG pathways gene sets from the Molecular 









 NHEK& NHDF§ HaCaT& HEK& HeLa§ HepG2§ HT29§ 
THP-
1& 
NHEK&  0.437 0.610 0.175 0.198 0.502 0.248 0.437 
NHDF§ 0.437  0.336 -0.321 -0.191 0.294 0.386 0.476 
HaCaT& 0.610 0.336  0.235 0.428 0.563 0.201 0.670 
HEK& 0.175 -0.321 0.235  0.758 -0.092 0.349 0.122 
HeLa§ 0.198 -0.191 0.428 0.758  0.388 0.558 0.223 
HepG2§ 0.502 0.294 0.563 -0.092 0.388  0.454 0.290 
HT29§ 0.248 0.386 0.201 0.349 0.558 0.454  0.155 
THP-1& 0.437 0.476 0.670 0.122 0.223 0.290 0.155  
Table S3. Pearson correlation of gene expression data from diverse cell lines 
treated with RSV. Pearson correlation coefficients for data presented in Fig. S3a-d. 
Results with P values lower than 0.05 (P < 0.05) displayed in italic font. & 50 µM 









e- H+ ∆E/∆pH 
pH EpH 
Reduced species 




per g protein) n 
Ehc,pH 
DMSO RSV DMSO RSV DMSO RSV 
DMS
O 
RSV DMSO RSV 
2GSH/GSSG -240 2 2 -61.50 
7.003 7.063 
-240.16 -243.89 20.71 27.68 0.45 0.47 2 -331.79 -342.55 
NADH/NAD+ -320 2 1 -30.75 -320.08 -321.94 0.43 0.12 4.50 4.84 2 -288.85 -272.83 
Lactate/pyruvate -190 2 2 -61.50 -190.16 -193.89 18.88 16.90 3.56 4.87 2 -212.46 -210.49 
NADPH/NADP+ -320 2 1 -30.75 -320.08 -321.94 595,341 310,219 27,978 17,903 2 -360.91 -360.03 
Table S4. Metabolites used to calculate the redox environment of the system. Values for NADPH and NADP (grey font) are relative 














































































































































SIRT1 23411 TGCAACAGCATCTTGCCTG 
AGGACATCGAGGAACTACC
TGATT 
Table S5. Primer sequences used for quantitative real-time PCR. 
